Entering text into the input field will update the search result below

Sanofi halts enrollment in studies of malaria drug in COVID-19

May 29, 2020 12:06 PM ETSanofi (SNY) StockSNYBy: Douglas W. House, SA News Editor6 Comments
  • Sanofi (SNY -0.2%) has apparently suspended recruitment in its studies testing the use of malaria med hydroxychloroquine in COVID-19 patients.
  • Developing...
  • Update: France, Italy and Belgium have paused a large study of the drug following an earlier WHO decision to do the same. The European Medicines Agency (EMA) continues to caution on the drug's safety profile, reiterating its position that its use should be restricted to clinical trials and emergency use programs while further analyses are done.
  • U.S. hospitals have backed away also. Orders have dropped 90% from the late-March peak to ~125K pills last week according to drug buyer Vizient.

Recommended For You

About SNY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SNY--
Sanofi